276 related articles for article (PubMed ID: 20207994)
1. SP1-dependent induction of CD39 facilitates hepatic ischemic preconditioning.
Hart ML; Gorzolla IC; Schittenhelm J; Robson SC; Eltzschig HK
J Immunol; 2010 Apr; 184(7):4017-24. PubMed ID: 20207994
[TBL] [Abstract][Full Text] [Related]
2. Contribution of E-NTPDase1 (CD39) to renal protection from ischemia-reperfusion injury.
Grenz A; Zhang H; Hermes M; Eckle T; Klingel K; Huang DY; Müller CE; Robson SC; Osswald H; Eltzschig HK
FASEB J; 2007 Sep; 21(11):2863-73. PubMed ID: 17442731
[TBL] [Abstract][Full Text] [Related]
3. CD39/ectonucleoside triphosphate diphosphohydrolase 1 provides myocardial protection during cardiac ischemia/reperfusion injury.
Köhler D; Eckle T; Faigle M; Grenz A; Mittelbronn M; Laucher S; Hart ML; Robson SC; Müller CE; Eltzschig HK
Circulation; 2007 Oct; 116(16):1784-94. PubMed ID: 17909107
[TBL] [Abstract][Full Text] [Related]
4. Beneficial effects of CD39/ecto-nucleoside triphosphate diphosphohydrolase-1 in murine intestinal ischemia-reperfusion injury.
Guckelberger O; Sun XF; Sévigny J; Imai M; Kaczmarek E; Enjyoji K; Kruskal JB; Robson SC
Thromb Haemost; 2004 Mar; 91(3):576-86. PubMed ID: 14983235
[TBL] [Abstract][Full Text] [Related]
5. Extracellular adenosine production by ecto-5'-nucleotidase protects during murine hepatic ischemic preconditioning.
Hart ML; Much C; Gorzolla IC; Schittenhelm J; Kloor D; Stahl GL; Eltzschig HK
Gastroenterology; 2008 Nov; 135(5):1739-1750.e3. PubMed ID: 18804111
[TBL] [Abstract][Full Text] [Related]
6. Central role of Sp1-regulated CD39 in hypoxia/ischemia protection.
Eltzschig HK; Köhler D; Eckle T; Kong T; Robson SC; Colgan SP
Blood; 2009 Jan; 113(1):224-32. PubMed ID: 18812468
[TBL] [Abstract][Full Text] [Related]
7. The Differential Effect of Apyrase Treatment and hCD39 Overexpression on Chronic Renal Fibrosis After Ischemia-Reperfusion Injury.
Roberts V; Campbell DJ; Lu B; Chia J; Cowan PJ; Dwyer KM
Transplantation; 2017 Jul; 101(7):e194-e204. PubMed ID: 28198766
[TBL] [Abstract][Full Text] [Related]
8. Deletion of CD39 on natural killer cells attenuates hepatic ischemia/reperfusion injury in mice.
Beldi G; Banz Y; Kroemer A; Sun X; Wu Y; Graubardt N; Rellstab A; Nowak M; Enjyoji K; Li X; Junger WG; Candinas D; Robson SC
Hepatology; 2010 May; 51(5):1702-11. PubMed ID: 20146261
[TBL] [Abstract][Full Text] [Related]
9. Ischemic Preconditioning protects hepatocytes from ischemia-reperfusion injury via TGR5-mediated anti-apoptosis.
Zhuang L; Fan Y; Lu L; Ding W; Ni C; Wang X; Zhang F; Rao J
Biochem Biophys Res Commun; 2016 May; 473(4):966-972. PubMed ID: 27045083
[TBL] [Abstract][Full Text] [Related]
10. Modulation of nucleoside [correction of nucleotide] triphosphate diphosphohydrolase-1 (NTPDase-1)cd39 in xenograft rejection.
Imai M; Takigami K; Guckelberger O; Enjyoji K; Smith RN; Lin Y; Csizmadia E; Sévigny J; Rosenberg RD; Bach FH; Robson SC
Mol Med; 1999 Nov; 5(11):743-52. PubMed ID: 10656876
[TBL] [Abstract][Full Text] [Related]
11. Adenosine and inflammation: CD39 and CD73 are critical mediators in LPS-induced PMN trafficking into the lungs.
Reutershan J; Vollmer I; Stark S; Wagner R; Ngamsri KC; Eltzschig HK
FASEB J; 2009 Feb; 23(2):473-82. PubMed ID: 18838482
[TBL] [Abstract][Full Text] [Related]
12. Development of a novel strategy to target CD39 antithrombotic activity to the endothelial-platelet microenvironment in kidney ischemia-reperfusion injury.
Sashindranath M; Dwyer KM; Dezfouli S; Selan C; Crikis S; Lu B; Yuan Y; Hickey MJ; Peter K; Robson SC; Cowan PJ; Nandurkar HH
Purinergic Signal; 2017 Jun; 13(2):259-265. PubMed ID: 28343356
[TBL] [Abstract][Full Text] [Related]
13. CD39 expression by hepatic myeloid dendritic cells attenuates inflammation in liver transplant ischemia-reperfusion injury in mice.
Yoshida O; Kimura S; Jackson EK; Robson SC; Geller DA; Murase N; Thomson AW
Hepatology; 2013 Dec; 58(6):2163-75. PubMed ID: 23813862
[TBL] [Abstract][Full Text] [Related]
14. Characterization of E-NTPDase (EC 3.6.1.5) activity in hepatic lymphocytes: A different activity profile from peripheral lymphocytes.
Doleski PH; Adefegha SA; Cabral FL; Leal DB
Cell Biochem Funct; 2017 Mar; 35(2):105-112. PubMed ID: 28217922
[TBL] [Abstract][Full Text] [Related]
15. Ectonucleoside triphosphate diphosphohydrolase 1/CD39, localized in neurons of human and porcine heart, modulates ATP-induced norepinephrine exocytosis.
Machida T; Heerdt PM; Reid AC; Schäfer U; Silver RB; Broekman MJ; Marcus AJ; Levi R
J Pharmacol Exp Ther; 2005 May; 313(2):570-7. PubMed ID: 15647328
[TBL] [Abstract][Full Text] [Related]
16. The impact of purinergic signaling on renal ischemia-reperfusion injury.
Lu B; Rajakumar SV; Robson SC; Lee EK; Crikis S; d'Apice AJ; Cowan PJ; Dwyer KM
Transplantation; 2008 Dec; 86(12):1707-12. PubMed ID: 19104409
[TBL] [Abstract][Full Text] [Related]
17. Reconstitution of CD39 in liposomes amplifies nucleoside triphosphate diphosphohydrolase activity and restores thromboregulatory properties.
Haller CA; Cui W; Wen J; Robson SC; Chaikof EL
J Vasc Surg; 2006 Apr; 43(4):816-23. PubMed ID: 16616242
[TBL] [Abstract][Full Text] [Related]
18. Vascular CD39/ENTPD1 directly promotes tumor cell growth by scavenging extracellular adenosine triphosphate.
Feng L; Sun X; Csizmadia E; Han L; Bian S; Murakami T; Wang X; Robson SC; Wu Y
Neoplasia; 2011 Mar; 13(3):206-16. PubMed ID: 21390184
[TBL] [Abstract][Full Text] [Related]
19. Delayed energy protection of ischemic preconditioning on hepatic ischemia/reperfusion injury in rats.
Ofluoglu E; Kerem M; Pasaoglu H; Turkozkan N; Seven I; Bedirli A; Utku Yilmaz T
Eur Surg Res; 2006; 38(2):114-21. PubMed ID: 16699285
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-6 and STAT3 protect the liver from hepatic ischemia and reperfusion injury during ischemic preconditioning.
Matsumoto T; O'Malley K; Efron PA; Burger C; McAuliffe PF; Scumpia PO; Uchida T; Tschoeke SK; Fujita S; Moldawer LL; Hemming AW; Foley DP
Surgery; 2006 Nov; 140(5):793-802. PubMed ID: 17084723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
